- Home
- HE vs SRPT Comparison
HE vs SRPT Comparison
Compare HE & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HE
- SRPT
- Stock Information
- Founded
- HE 1891
- SRPT 1980
- Country
- HE United States
- SRPT United States
- Employees
- HE N/A
- SRPT N/A
- Industry
- HE Electric Utilities: Central
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- HE Utilities
- SRPT Health Care
- Exchange
- HE Nasdaq
- SRPT Nasdaq
- Market Cap
- HE 2.0B
- SRPT 1.9B
- IPO Year
- HE N/A
- SRPT 1997
- Fundamental
- Price
- HE $11.79
- SRPT $21.03
- Analyst Decision
- HE Hold
- SRPT Hold
- Analyst Count
- HE 3
- SRPT 28
- Target Price
- HE $11.25
- SRPT $26.00
- AVG Volume (30 Days)
- HE 2.0M
- SRPT 6.2M
- Earning Date
- HE 11-07-2025
- SRPT 11-03-2025
- Dividend Yield
- HE N/A
- SRPT N/A
- EPS Growth
- HE N/A
- SRPT N/A
- EPS
- HE 0.09
- SRPT N/A
- Revenue
- HE $3,080,252,000.00
- SRPT $2,413,715,000.00
- Revenue This Year
- HE $12.58
- SRPT $10.20
- Revenue Next Year
- HE $2.10
- SRPT N/A
- P/E Ratio
- HE $18.15
- SRPT N/A
- Revenue Growth
- HE 3.28
- SRPT 47.15
- 52 Week Low
- HE $8.14
- SRPT $10.42
- 52 Week High
- HE $13.41
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- HE 56.47
- SRPT 56.90
- Support Level
- HE $11.09
- SRPT $15.94
- Resistance Level
- HE $11.88
- SRPT $20.15
- Average True Range (ATR)
- HE 0.31
- SRPT 1.32
- MACD
- HE 0.02
- SRPT 0.31
- Stochastic Oscillator
- HE 91.98
- SRPT 97.88
About HE Hawaiian Electric Industries Inc.
Hawaiian Electric Industries is the parent company of three Hawaii-based regulated utilities and owns a 10% minority interest in Hawaii's American Savings Bank. The utilities provide electricity on the five islands of Oahu, Hawaii, Maui, Molokai, and Lanai.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.